Grants

PI Name Sort descending PI Organization Title Grant Number Initiative Program Director
Gray, Robert J

Dana-Farber Cancer Inst
United States

Analysis of ECOG-ACRIN adverse event data to optimize strategies for the longitudinal assessment of tolerability in the context of evolving cancer treatment paradigms (EVOLV) 5U01CA233169-05 Diane St Germain, R.N., M.S., C.R.N.P.
Gross, Howard M

Dayton Clinical Oncology Program
United States

Dayton Clinical Oncology Program 5UG1CA189957-09 Worta McCaskill-Stevens, M.D., M.S.
Grueber, Wesley B

Columbia University Health Sciences
United States

Neuron-macrophage interactions in models of chemotherapy-induced peripheral neuropathy 1R21CA274588-01 PAR-20-292 (R21 Clinical Trial Optional) Alexis Bakos, Ph.D., M.P.H., R.N.
Halmos, Balazs

Montefiore Medical Center (Bronx, Ny)
United States

MINORITY-BASED COMMUNITY ONCOLOGY PROGRAM 5UG1CA189859-09 Worta McCaskill-Stevens, M.D., M.S.
Hanks, Brent Allen

Duke University
United States

Role of the tumor NLRP3 inflammasome in the generation of anti-PD-1 antibody immunotherapy-associated toxicities 5R01CA251136-02 PAR-19-325 (R01 Clinical Trial Optional) Alexis Bakos, Ph.D., M.P.H., R.N.
Hanks, Brent Allen

Duke University
United States

Role of the tumor NLRP3 inflammasome in the generation of anti-PD-1 antibody immunotherapy-associated toxicities 5R01CA251136-02 PAR-19-325 (R01 Clinical Trial Optional) Alexis Bakos, Ph.D., M.P.H., R.N.
Herrmann, Joerg

Mayo Clinic Rochester
United States

TrAstuzumab Cardiomyopathy Therapeutic Intervention with Carvedilol (TACTIC) Trial 5R01CA233610-05 PA-18-003 (R01 Clinical Trial Optional)
Hill, Deirdre

University Of New Mexico Health Scis Ctr
United States

Chronic Kidney Disease Development in Cancer Treatment and Survival 1R21CA264805-01 PAR-20-292 (R21 Clinical Trial Optional) Alexis Bakos, Ph.D., M.P.H., R.N.
Hinds, Pamela S

Children'S Research Institute
United States

Longitudinal, multimodal assessment of neuropsychological functioning in children diagnosed with high-risk acute lymphoblastic leukemia (HR-ALL): Using early changes to predict later impairment 5R01CA212190-05 Alexis Bakos, Ph.D., M.P.H., R.N.
Hoffman, Amy Jude

University Of Nebraska Medical Center
United States

Managing Fatigue Using Virtual Reality for Post-Operative Lung Cancer Patients 5R01CA205025-06 Alexis Bakos, Ph.D., M.P.H., R.N.